title: A highly potent, orally active imidazo[4,5-b]pyridine biphenylacylsulfonamide (MK-996; L-159,282): a new AT1-selective angiotensin II receptor antagonist.
authors.affiliation: Merck Research Laboratories, Rahway, New Jersey 07065.
authors.forename: P K
authors.initials: PK
authors.lastname: Chakravarty
authors.forename: E M
authors.initials: EM
authors.lastname: Naylor
authors.forename: A
authors.initials: A
authors.lastname: Chen
authors.forename: R S
authors.initials: RS
authors.lastname: Chang
authors.forename: T B
authors.initials: TB
authors.lastname: Chen
authors.forename: K A
authors.initials: KA
authors.lastname: Faust
authors.forename: V J
authors.initials: VJ
authors.lastname: Lotti
authors.forename: S D
authors.initials: SD
authors.lastname: Kivlighn
authors.forename: R A
authors.initials: RA
authors.lastname: Gable
authors.forename: G J
authors.initials: GJ
authors.lastname: Zingaro
mesh_terms: D000284:Administration, Oral; D000804:Angiotensin II / Q000037:antagonists & inhibitors*; D057911:Angiotensin Receptor Antagonists; D000818:Animals; D000959:Antihypertensive Agents / Q000138:chemical synthesis / Q000494:pharmacology*; D004285:Dogs; D007093:Imidazoles / Q000138:chemical synthesis / Q000494:pharmacology*; D008253:Macaca mulatta; D011725:Pyridines / Q000138:chemical synthesis / Q000494:pharmacology*; D051381:Rats
chemical_list: D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents; D007093:Imidazoles; D011725:Pyridines; D000804:Angiotensin II; C090789:MK 996